M. Schultz

Docetaxel (Taxotere) as monotherapy in the treatment of hormone-refractory prostate cancer: preliminary results.

J. Picus, M. Schultz, 1999, Seminars in oncology.

Bolus thrombolytic infusions during CPR for patients with refractory arrest rhythms: outcome of a case series.

M. Schultz, H. Stueven, P. Tiffany, 1998, Annals of emergency medicine.

A phase I pilot study of BCNU plus thymidine in patients with refractory cancer.

M. Schultz, A. Sandler, D. Cooper, 1996, Cancer investigation.

Docetaxel-induced extravasation injury: a report of three cases

M. Schultz, S. Yackzan, B. Harrison, 2000 .

Critical Care of Intrathoracic Complications of Lung Cancer

M. Schultz, J. Murren, 1994 .

Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases.

J. Lacy, G. Tallini, M. Schultz, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase II study of interferon-alpha 2b with dacarbazine, carmustine, cisplatin and tamoxifen in metastatic melanoma.

A. Buzaid, M. Schultz, W. Poo, 1997, Melanoma research.